The report is based on a small study of more than 200 adults that was published in a JAMA Network Open research letter.
There were no instances of gastric food retention for patients who underwent a combined EGD-colonoscopy, regardless of GLP-1 drug use, according to the letter.
Among the group undergoing an EGD alone, food retention occurred in 17.4% of patients on a GLP-1 drug. Of the four cases of retention, one was graded as moderate and three were graded as large.
GLP-1 agonist users undergoing colonoscopy were more likely to have inadequate bowel preparation versus non-users.
The study included 209 patients undergoing an EGD alone (33%), a colonoscopy alone (33%), or a combined procedure (34%) from January to June 2023.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
